Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05470478 · ClinicalTrials.gov registry record · NA
iBCI Optimization for Veterans With Paralysis
A NA study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT05470478: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT05470478 is a NA study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05470478, a NA study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
VA research has been advancing a high-performance brain-computer interface (BCI) to improve independence for Veterans and others living with tetraplegia or the inability to speak resulting from amyotrophic lateral sclerosis, spinal cord injury or stoke. In this project, the investigators enhance deep learning neural network decoders and multi-state gesture decoding for increased accuracy and reliability and deploy them on a battery-powered mobile BCI device for independent use of computers and touch-enabled mobile devices at home. The accuracy and usability of the mobile iBCI will be evaluated with participants already enrolled separately in the investigational clinical trial of the BrainGate neural interface.
Primary Outcome
Rate of successful closed-loop acquisition of on-screen targets using imagined gestures to move a computer cursor or to select icons on a computer screen.
Interventions
- DEVICE Mobile neural decoding platform (mobile iBCI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2026-06-16 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What is known before NCT05470478 opens enrollment
NCT05470478 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Mobile neural decoding platform (mobile iBCI) is the first listed.
NCT05470478 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05470478 about?
NCT05470478 is a clinical study titled "iBCI Optimization for Veterans With Paralysis". VA research has been advancing a high-performance brain-computer interface (BCI) to improve independence for Veterans and others living with tetraplegia or the inability to speak resulting from amyotrophic lateral sclerosis, spinal cord injury or stoke. In this project, the investigators enhance dee...
What is the current status of trial NCT05470478?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 2 participants. The study started on 2026-06-16. Estimated completion is 2027-06-30.
What interventions are being tested in trial NCT05470478?
The interventions under investigation include: Mobile neural decoding platform (mobile iBCI) (DEVICE).
Who is sponsoring clinical trial NCT05470478?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05470478's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI